Pacer Advisors, Inc. Bio Rad Laboratories, Inc. Transaction History

Pacer Advisors, Inc.

  • $41.8 Billion
  • Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 2,812 shares of BIO stock, worth $960,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,812
Previous 2,579 9.03%
Holding current value
$960,326
Previous $704,000 33.52%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$263.97 - $344.64 $61,505 - $80,301
233 Added 9.03%
2,812 $940,000
Q2 2024

Aug 13, 2024
BUY
$268.26 - $339.48 $301,524 - $381,575
1,124 Added 77.25%
2,579 $704,000
Q1 2024

May 10, 2024
BUY
$304.11 - $351.99 $11,556 - $13,375
38 Added 2.68%
1,455 $503,000
Q4 2023

Jan 16, 2024
SELL
$269.37 - $365.04 $787,907 - $1.07 Million
-2,925 Reduced 67.37%
1,417 $457,000
Q3 2023

Nov 13, 2023
BUY
$350.25 - $422.63 $218,556 - $263,721
624 Added 16.78%
4,342 $1.56 Million
Q2 2023

Jul 12, 2023
BUY
$359.49 - $486.4 $634,859 - $858,982
1,766 Added 90.47%
3,718 $1.41 Million
Q1 2023

May 02, 2023
BUY
$418.69 - $503.0 $667,810 - $802,285
1,595 Added 446.78%
1,952 $935,000
Q4 2022

Feb 06, 2023
SELL
$351.71 - $456.01 $366,481 - $475,162
-1,042 Reduced 74.48%
357 $150,000
Q3 2022

Oct 18, 2022
BUY
$412.59 - $563.26 $37,133 - $50,693
90 Added 6.88%
1,399 $584,000
Q2 2022

Aug 12, 2022
SELL
$463.67 - $597.16 $361,662 - $465,784
-780 Reduced 37.34%
1,309 $648,000
Q1 2022

Apr 05, 2022
BUY
$524.57 - $735.42 $488,374 - $684,676
931 Added 80.4%
2,089 $1.18 Million
Q4 2021

Feb 03, 2022
SELL
$708.84 - $794.68 $591,172 - $662,763
-834 Reduced 41.87%
1,158 $875,000
Q3 2021

Oct 15, 2021
SELL
$657.71 - $825.77 $203,232 - $255,162
-309 Reduced 13.43%
1,992 $1.49 Million
Q2 2021

Jul 21, 2021
BUY
$576.64 - $649.04 $625,654 - $704,208
1,085 Added 89.23%
2,301 $1.48 Million
Q1 2021

Apr 05, 2021
SELL
$547.01 - $662.35 $106,666 - $129,158
-195 Reduced 13.82%
1,216 $695,000
Q4 2020

Jan 20, 2021
SELL
$510.68 - $643.45 $564,812 - $711,655
-1,106 Reduced 43.94%
1,411 $823,000
Q3 2020

Oct 19, 2020
SELL
$454.43 - $535.6 $176,318 - $207,812
-388 Reduced 13.36%
2,517 $1.3 Million
Q2 2020

Jul 29, 2020
BUY
$334.87 - $493.06 $962,081 - $1.42 Million
2,873 Added 8978.13%
2,905 $1.31 Million
Q1 2020

Apr 23, 2020
SELL
$320.01 - $409.07 $2.34 Million - $2.99 Million
-7,309 Reduced 99.56%
32 $14,000
Q4 2019

Feb 10, 2020
SELL
$319.73 - $374.2 $136,524 - $159,783
-427 Reduced 5.5%
7,341 $2.72 Million
Q3 2019

Oct 10, 2019
SELL
$304.55 - $345.24 $86,492 - $98,048
-284 Reduced 3.53%
7,768 $2.59 Million
Q2 2019

Aug 12, 2019
BUY
$286.93 - $312.59 $2.3 Million - $2.5 Million
8,012 Added 20030.0%
8,052 $2.52 Million
Q1 2019

Apr 10, 2019
SELL
$224.3 - $317.41 $10,542 - $14,918
-47 Reduced 54.02%
40 $12,000
Q4 2018

Feb 13, 2019
SELL
$220.1 - $309.0 $1.58 Million - $2.21 Million
-7,165 Reduced 98.8%
87 $20,000
Q3 2018

Nov 14, 2018
BUY
$289.28 - $326.15 $245,309 - $276,575
848 Added 13.24%
7,252 $2.27 Million
Q2 2018

Aug 14, 2018
BUY
$244.1 - $303.88 $212,611 - $264,679
871 Added 15.74%
6,404 $1.85 Million
Q1 2018

May 14, 2018
BUY
$233.97 - $274.11 $155,824 - $182,557
666 Added 13.68%
5,533 $1.38 Million
Q4 2017

Feb 14, 2018
BUY
$216.94 - $271.3 $237,766 - $297,344
1,096 Added 29.06%
4,867 $1.16 Million
Q3 2017

Nov 08, 2017
BUY
$212.27 - $242.28 $800,470 - $913,637
3,771
3,771 $838,000

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.41B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email